Clinical Trial: Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Open-Label Treatment Trial to Assess the Short-Term Tolerability, Safety, and Efficacy of Methylphenidate Hydrochloride Extended-Release Liquid Formulation in High-Functioning Autism Spectrum Disorder

Brief Summary: The purpose of this study is to determine whether methylphenidate hydrochloride extended release liquid formulation is safe and effective in the treatment of attention-deficit/hyperactivity disorder (ADHD) in high-functioning adults with autism spectrum disorders (ASD).